Relative Bioavailability and the Effect of Food on the Bioavailability of LY2801653 in Healthy Subjects

Trial Profile

Relative Bioavailability and the Effect of Food on the Bioavailability of LY2801653 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2015

At a glance

  • Drugs Merestinib (Primary)
  • Indications Cancer
  • Focus Pharmacokinetics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 18 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 02 Jun 2015 Planned End Date changed from 1 May 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
    • 02 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top